SavedAdd your journal

Journals / Türk Kolon ve Rektum Hastalıkları Dergisi / 2021 / Cilt: 31 - Sayı: 4

Factors Associated with Poor Lymph Node Dissection of Colon Neoplasm

Kolon Kanseri Cerrahisinde Yetersiz Lenf Nodu Çıkarılması ile İlişkili Risk Faktörleri

Pervin Demir
Aysun Gökçe
Mehmet Saydam
İbrahim Yılmaz
Mustafa Taner Bostancı
Ahmet Seki
Gökşen İnanç İmamoğlu
Pages
322–329
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aim: Dissection of ≥12 lymph nodes is recommended for curative surgery of colon neoplasms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Dissection of ≥12 lymph nodes is recommended for curative surgery of colon neoplasms.
📊
Key Findings & Data:Method: Patient hospital records in those undergoing surgery due to stage 1-3 colon neoplasm, between January 2009 and December 2017, were retrospectively evaluated.
💡
Conclusion & Impact:Results: The patient population during the study period numbered 388.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Dissection of ≥12 lymph nodes is recommended for curative surgery of colon neoplasms. The aim was to determine the clinicopathological factors associated with poor lymph node dissection. Method: Patient hospital records in those undergoing surgery due to stage 1-3 colon neoplasm, between January 2009 and December 2017, were retrospectively evaluated. Univariate and multivariate analyses were performed to evaluate the clinical and pathological risk factors associated with poor lymph node dissection. Results: The patient population during the study period numbered 388. Of these,

Özet

Amaç: Kolon kanserinin küratif cerrahisinde ≥12 lenf nodunun diseke edilmesi önerilmektedir. Bu çalışmada yetersiz lenf nodu diseksiyonuna etki eden klinikopatolojik faktörleri belirlemeyi amaçladık. Yöntem: Ocak 2009-Aralık 2017 tarihleri arasında evre 1-3 kolon kanseri tanısıyla opere ettiğimiz hastalar retrospektif olarak incelenmiştir. Yetersiz lenf nodu diseksiyonu için risk faktörü olan klinik ve patolojik veriler tek değişkenli ve çok değişkenli analizlerle değerlendirilmiştir. Bulgular: Çalışmaya 388 evre 1-3 kolon kanseri hasta dahil edilmiştir. Hastaların %21,9’da

🔖

Cite This Article

Demir, P., Gökçe, A., Saydam, M., Yılmaz, İ., Bostancı, M. T., Seki, A., İmamoğlu, G. İ. (2022). Factors Associated with Poor Lymph Node Dissection of Colon Neoplasm. Türk Kolon ve Rektum Hastalıkları Dergisi, Cilt: 31 - Sayı: 4, 322–329. https://ajindex.com/articles/634520

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargent D, National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583- 596. Huh JW, Kim CH, Kim HR, Kim HR, Kim YJ. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer. J Surg Oncol 2012;105:125-129.
  2. Namm J, Ng M, Roy-Chowdhury S, Morgan JW, Lum SS, Wong JH. Quantitating the impact of stage migration on staging accuracy in colorectal cancer. J Am Coll Surg 2008;207:882-887.
  3. Tsai HL, Yeh YS, Yu FJ, Lu CY, Chen CF, Chen CW, Chang YT, Wang JY. Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes. Int J Colorectal Dis 2009;24:177-183.
  4. Shanmugam C, Hines RB, Jhala NC, Katkoori VR, Zhang B, Jr JAP, Bumpers HL, Grizzle WE, Eltoum IE, Siegal GP, Manne U. Evaluation of lymph node numbers for the adequate staging of Stage II and III colon cancer. J Hematol Oncol 2011;4:25. Iachetta F, Reggiani BL, Marcheselli L, Gregoria CD, Cirilli C, Messinese S, Cervo GL, Postiglione R, Emidio KD, Pedroni M, Longinotti E, Federico M, de MP. Leon Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study. Acta Oncol 2013;52:1682-1690.
  5. Gönen M, Schrag D, Weiser MR. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 2009;27:6166- 6171. Shia J, Wang H, Nash GM, Klimstra DS. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J Am Coll Surg 2012;214:348-355.
  6. Chen HH, Chakravarty KD, Wang JY, Changchien CR, Tang R. Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2,056 consecutive patients in NE. Reftwo branches of the same institution. Int J Color Dis 2010;25:1333- 1341. Tsai HL, Huang CW, Yeh YS, Ma CJ, Chen CW, Lu CY, Huang MY, Yang IP, Wang JY. Factors affecting the number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I-III colorectal cancer patients: a retrospective single-institution cohort study of 1167 consecutive patients. BMC Surg 2016;16:17. American Joint Committee on Cancer. Cancer staging manual (5th ed): Springer; 1997: pp. 83-91.
  7. Bilimoria KY, Bentrem DJ, Stewart AK, Talamonti MS, Winchester